Company intelligence / Profile preview

Krka

Novo mesto, Sloveniakrka.biz ↗

Ownership: Public · KRKG
Employees: ~12753
Development stage: Commercial

Overview

Krka is one of the world’s leading generic pharmaceutical companies with over a thousand marketed products across more than seventy countries. Its portfolio includes numerous approved small molecule drugs for cardiovascular disease, diabetes, CNS disorders, oncology and more. The company is known for innovative fixed-dose combinations in hypertension and lipid management as well as expanding into new areas such as novel oral anticoagulants.

Therapeutic areas: GastroenterologyPulmonologyCardiovascularNephrologyEndocrinologyHematologyOncologyNeurologyInfectious Diseases
Modalities: Small moleculeSynthetic peptideDegradable molecular glue therapy
Industry: Biotech

Drug pipeline

1 asset

Krka

Unknown

Partnerships

Not specifically listed; operates independently with global distribution network.

Financials

Market cap: $45.3B
Total revenue: $147.1B
Enterprise value: $68.3B

Beyond the preview

Go deeper on Krka.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Krka.

Explore the full profile